Legal & General Group Plc trimmed its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 13.6% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 134,791 shares of the company’s stock after selling 21,220 shares during the period. Legal & General Group Plc’s holdings in Acadia Healthcare were worth $8,458,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Twin Tree Management LP bought a new position in Acadia Healthcare in the 2nd quarter valued at $36,000. Eagle Bay Advisors LLC bought a new position in Acadia Healthcare in the 2nd quarter valued at $85,000. MML Investors Services LLC bought a new position in Acadia Healthcare in the 1st quarter valued at $213,000. XTX Topco Ltd bought a new position in Acadia Healthcare in the 1st quarter valued at $219,000. Finally, Bridgefront Capital LLC acquired a new position in shares of Acadia Healthcare in the 2nd quarter valued at $268,000.
A number of research analysts have recently weighed in on the company. Seaport Global Securities assumed coverage on Acadia Healthcare in a research note on Friday, July 9th. They issued a “neutral” rating and a $63.23 price target on the stock. Zacks Investment Research raised Acadia Healthcare from a “hold” rating to a “buy” rating and set a $62.00 price target on the stock in a research note on Monday, July 19th. Barclays assumed coverage on Acadia Healthcare in a research note on Thursday, August 12th. They issued an “underweight” rating and a $69.00 price target on the stock. Deutsche Bank Aktiengesellschaft increased their price target on Acadia Healthcare from $62.00 to $70.00 and gave the company a “hold” rating in a research note on Wednesday, August 4th. Finally, SVB Leerink started coverage on Acadia Healthcare in a research note on Monday, September 27th. They issued an “outperform” rating and a $85.00 price target on the stock. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of $66.88.
Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Sunday, August 1st. The company reported $0.71 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.63 by $0.08. The firm had revenue of $582.20 million during the quarter, compared to analysts’ expectations of $560.88 million. Acadia Healthcare had a positive return on equity of 11.70% and a negative net margin of 27.61%. The company’s revenue was up 18.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.54 EPS. On average, analysts forecast that Acadia Healthcare Company, Inc. will post 2.6 earnings per share for the current fiscal year.
Acadia Healthcare Profile
Acadia Healthcare Co, Inc engages in the provision of behavioral healthcare services. It operates through the following business segments: United States (U.S.) Facilities and the United Kingdom (U.K.) Facilities. The U.S. Facilities segment classified in the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; residential treatment centers; and outpatient community-based services.
Read More: What can cause a stock to outperform?
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC).
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.